NBA Star and Television Personality John Salley Joins One World Pharma’s Board of Advisors

LAS VEGAS, NV, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Pharma Inc. (OTC: OWPC), (“OWP” or the “Company”), a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that NBA star, television personality and businessman John Salley has joined the Company’s growing Board of Advisors.

As the #11 selection in the 1986 NBA Draft, Mr. Salley played 15 years in the NBA and was the first player to win four championships with three different teams.  During the 1980s, Salley was a member of the iconic Detroit Pistons “Bad Boys” squad alongside NBA All-Time great and One World Pharma CEO Isiah Thomas. Salley would later win championships with the Chicago Bulls and Los Angeles Lakers. He has continued his success in film and television and is considered a highly influential voice in sports and popular culture.  Mr. Salley is also an entrepreneur in the cannabis industry, launching his own brand Deuces22 and taking an ownership stake in the cannabis testing company Greenspace Labs. He also is an advisory member of Budtrader.

Mr. Salley joins a growing Board of Advisors that is chaired by Minyon Moore, who is widely considered one of the nation’s top strategic thinkers with extensive experience in political and corporate affairs as well as public policy. Ms. Moore was named one of the 100 Most Powerful Women in Washington by Washington Magazine, and has been inducted into the American Association of Political Consultants (AAPC) Hall of Fame.

“John was not just my teammate on one of the most successful championship teams in NBA history, he is a creative executive with an incredible history of winning in sports, entertainment, and more,” said Isiah Thomas, CEO, of One World Pharma. “I fully expect John to contribute immediately, to provide both advice and introductions, and to be an integral part of our effort to be an international supplier of the finest cannabis ingredients in the marketplace.”

“It is my distinct pleasure to once again join my teammate and dear friend Isiah in the pursuit of excellence in an industry where I am deeply passionate,” stated John Salley. “I’ve watched with interest since Isiah first came on board with One World Pharma and noted with admiration how he has steered the Company to the broader opportunities within the cannabis industry and done so with a model grounded in socially conscious business practices.”

About One World Pharma

Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia. 

One World Pharma Investor Relations & Financial Media
Kurt Divich, CEO
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com

Information about Forward-Looking Statements

This press release contains “forward-looking statements” that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the failure to close the remaining funding installments with ISIAH International, the Company’s need for additional funding, the demand for the Company’s products, governmental regulation of the cannabis industry, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.